Does a pregnancy with Sickle Cell Disease (SCD) require a visit to a Maternal-Fetal Medicine (MFM) specialist?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pregnancy with Sickle Cell Disease Requires MFM Referral

Yes, pregnancy with sickle cell disease (SCD) requires referral to and co-management by a Maternal-Fetal Medicine (MFM) specialist. This is a high-risk pregnancy with substantial maternal and fetal morbidity and mortality risks that necessitate specialized care. 1

Why MFM Referral is Essential

For most women at increased risk of maternal morbidity and mortality, referral to an MFM subspecialist is appropriate. 1 SCD pregnancy specifically falls into this high-risk category because:

  • Pregnancy increases the rate of SCD-related complications including pain episodes, acute chest syndrome, and maternal death 1
  • Maternal complications occur at high rates: 57% experience painful crises, 23% require ICU admission, and there is increased risk of preeclampsia and miscarriage 2
  • Fetal complications include low birth weight, small for gestational age, stillbirth (up to 20% fetal mortality in some series), preterm delivery (5-6%), and intrauterine growth restriction due to placental insufficiency 1, 3
  • Maternal mortality can reach 11.4% in some reports 3

Multidisciplinary Team Approach Required

When an adolescent or adult with SCD becomes pregnant, co-management by a hematologist with expertise in SCD and a high-risk obstetrician is essential. 1 This multidisciplinary team should include:

  • MFM specialist for high-risk obstetrical management 1
  • Hematologist experienced in SCD 1, 2
  • Anesthesiology for pain crisis management and delivery planning 2
  • Access to tertiary care center capabilities 1, 4

Level of Care Considerations

Pregnant patients with SCD should ideally be managed throughout pregnancy, delivery, and postpartum at centers with multidisciplinary teams experienced in treating high-risk diseases. 1 This is similar to recommendations for other complex medical conditions in pregnancy, where tertiary maternal health services are preferred. 4

Timing of Referral

The referral should occur:

  • Preconception: When possible, women with SCD should receive preconception counseling from MFM to discuss risks and optimize health before pregnancy 1
  • Early pregnancy: If pregnancy is unplanned, MFM referral should occur as soon as pregnancy is confirmed to establish the care plan 1

What MFM Management Provides

MFM specialists coordinate:

  • Risk stratification and continuous risk assessment throughout pregnancy 1
  • Decisions regarding transfusion therapy (prophylactic vs. on-demand) based on individual risk factors 1
  • Monitoring for SCD complications and pregnancy-specific complications 5
  • Delivery planning and timing 1
  • Postpartum management 4

Common Pitfall to Avoid

Do not manage SCD pregnancy in a standard obstetrical setting without MFM involvement. Even women with milder SCD phenotypes or those without recent complications require specialized monitoring, as pregnancy itself increases the inflammatory and thrombogenic state that promotes vaso-occlusion. 2 The physiological changes of pregnancy (increased metabolic demand, susceptibility to infection, pro-thrombotic state, and aortocaval compression) can precipitate sickle complications even in previously stable patients. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pain Management in Pregnant Patients with Sickle Cell Crisis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pregnancy and sickle cell disease: A review of the current literature.

Critical reviews in oncology/hematology, 2016

Research

[Sickle cell disease and pregnancy].

La Revue du praticien, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.